{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:57:30Z","timestamp":1791406650561,"version":"4.3.3"},"reference-count":52,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.4158\/ep.14.6.782","type":"journal-article","created":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T22:08:50Z","timestamp":1365199730000},"page":"782-790","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":152,"title":["Inhibition of Renal Glucose Reabsorption: A Novel Strategy for Achieving Glucose Control in Type 2 Diabetes Mellitus"],"prefix":"10.1016","volume":"14","author":[{"given":"Muhammad A.","family":"Abdul-Ghani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph A.","family":"DeFronzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP.14.6.782_bb0005","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.2337\/diacare.21.9.1414","article-title":"Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections","volume":"21","author":"King","year":"1998","journal-title":"Diabetes Care"},{"key":"10.4158\/EP.14.6.782_bb0010","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1042\/CS20050025","article-title":"Vascular complications in diabetes mellitus: the role of endothelial dysfunction","volume":"109","author":"Schalkwijk","year":"2005","journal-title":"Clin Sci (Lond)"},{"key":"10.4158\/EP.14.6.782_bb0015","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ecl.2003.12.003","article-title":"Microvascular complications of diabetes","volume":"33","author":"He","year":"2004","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"1, pt 2","key":"10.4158\/EP.14.6.782_bb0020","doi-asserted-by":"crossref","first-page":"90","DOI":"10.7326\/0003-4819-124-1_Part_2-199601011-00003","article-title":"Relation of glycemic control to diabetic microvascular complications in diabetes mellitus","volume":"124","author":"Klein","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.4158\/EP.14.6.782_bb0025","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Diabetes Control and Complications Trial Research Group","year":"1993","journal-title":"N Engl J Med"},{"key":"10.4158\/EP.14.6.782_bb0030","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) [published correction appears in Lancet. 1999;354:602]","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","journal-title":"Lancet"},{"issue":"suppl 1","key":"10.4158\/EP.14.6.782_bb0035","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.2337\/dc07-S004","article-title":"Standards of medical care in diabetes\u20142007","volume":"30","author":"American Diabetes Association","year":"2007","journal-title":"Diabetes Care"},{"key":"10.4158\/EP.14.6.782_bb0040","doi-asserted-by":"crossref","first-page":"417","DOI":"10.7326\/0003-4819-147-6-200709180-00012","article-title":"Glycemic control and type 2 diabetes mellitus: the optimal hemoglobin A1c targets; a guidance statement from the American College of Physicians","volume":"147","author":"Qaseem","year":"2007","journal-title":"Ann Intern Med"},{"issue":"suppl 1","key":"10.4158\/EP.14.6.782_bb0045","first-page":"1","article-title":"American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus","volume":"13","author":"AACE Diabetes Mellitus Clinical Practice Guidelines Task Force","year":"2007","journal-title":"Endocr Pract"},{"key":"10.4158\/EP.14.6.782_bb0050","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s00125-007-0873-z","article-title":"Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy; update regarding the thiazolidinediones","volume":"51","author":"Nathan","year":"2008","journal-title":"Diabetologia"},{"key":"10.4158\/EP.14.6.782_bb0055","series-title":"Renal Function","first-page":"65","article-title":"Tubular reabsorption","author":"Valtin","year":"1983"},{"key":"10.4158\/EP.14.6.782_bb0060","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2796.2006.01746.x","article-title":"Active sugar transport in health and disease","volume":"261","author":"Wright","year":"2007","journal-title":"J Intern Med"},{"key":"10.4158\/EP.14.6.782_bb0065","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1097\/01.ASN.0000092790.89332.D2","article-title":"Molecular analysis of the SGLT2 gene in patients with renal glucosuria","volume":"14","author":"Santer","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.4158\/EP.14.6.782_bb0070","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1016\/S0024-3205(01)01090-6","article-title":"Renal glucose reabsorption during hypertonic glucose infusion in female streptozotocin-induced diabetic rats","volume":"68","author":"Noonan","year":"2001","journal-title":"Life Sci"},{"issue":"2, pt 2","key":"10.4158\/EP.14.6.782_bb0075","first-page":"F283","article-title":"Molecular adaptations of GLUT1 and GLUT2 in renal proximal tubules of diabetic rats","volume":"266","author":"Dominguez","year":"1994","journal-title":"Am J Physiol"},{"issue":"5, suppl 1","key":"10.4158\/EP.14.6.782_bb0080","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1681\/ASN.V55s29","article-title":"Gene expression of epithelial glucose transporters: the role of diabetes mellitus","volume":"5","author":"Dominguez","year":"1994","journal-title":"J Am Soc Nephrol"},{"key":"10.4158\/EP.14.6.782_bb0085","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1681\/ASN.V86943","article-title":"Over - expression of GLUT2 gene in renal proximal tubules of diabetic Zucker rats","volume":"8","author":"Kamran","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"10.4158\/EP.14.6.782_bb0090","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1210\/en.2007-1088","article-title":"Na(+)-glucose transporter-2 messenger ribonucleic acid expression in kidney of diabetic rats correlates with glycemic levels: involvement of hepatocyte nuclear factor-1alpha expression and activity","volume":"149","author":"Freitas","year":"2008","journal-title":"Endocrinology"},{"key":"10.4158\/EP.14.6.782_bb0095","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.2337\/diabetes.54.12.3427","article-title":"Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes","volume":"54","author":"Rahmoune","year":"2005","journal-title":"Diabetes"},{"key":"10.4158\/EP.14.6.782_bb0100","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/00365517109090668","article-title":"Maximum tubular reabsorption capacity for glucose and renal hemodynamics during rapid hypertonic glucose infusion in normal and diabetic subjects","volume":"28","author":"Mogensen","year":"1971","journal-title":"Scand J Lab Clin Invest"},{"key":"10.4158\/EP.14.6.782_bb0105","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1172\/JCI112981","article-title":"Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats","volume":"79","author":"Rossetti","year":"1987","journal-title":"J Clin Invest"},{"key":"10.4158\/EP.14.6.782_bb0110","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI115031","article-title":"Normalization of blood glucose in diabetic rats with phlorizin treatment reverses insulin-resistant glucose transport in adipose cells without restoring glucose transporter gene expression","volume":"87","author":"Kahn","year":"1991","journal-title":"J Clin Invest"},{"key":"10.4158\/EP.14.6.782_bb0115","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1172\/JCI113157","article-title":"Effect of chronic hyperglycemia on in vivo insulin secretion in partially pancreatectomized rats","volume":"80","author":"Rossetti","year":"1987","journal-title":"J Clin Invest"},{"key":"10.4158\/EP.14.6.782_bb0120","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1124\/jpet.106.110296","article-title":"Sergliflozin, a novel selective inhibitor of low-affinity sodium glucose cotransporter (SGLT2), validates the critical role of SGLT2 in renal glucose reabsorption and modulates plasma glucose level","volume":"320","author":"Katsuno","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.4158\/EP.14.6.782_bb0125","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1124\/jpet.107.129825","article-title":"Inhibitor binding in the human renal low- and high-affinity Na+\/glucose cotransporters","volume":"324","author":"Pajor","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.4158\/EP.14.6.782_bb0130","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1021\/jm701272q","article-title":"Discovery of dapagliflozin: a potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes","volume":"51","author":"Meng","year":"2008","journal-title":"J Med Chem"},{"key":"10.4158\/EP.14.6.782_bb0135","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.2337\/db07-1472","article-title":"Dapagliflozin, a selective SGLT2 inhibitor, improves glucose homeostasis in normal and diabetic rats","volume":"57","author":"Han","year":"2008","journal-title":"Diabetes"},{"issue":"suppl 1","key":"10.4158\/EP.14.6.782_bb0140","first-page":"A334","article-title":"Long term safety and efficacy of ISIS 388626, an optimized SGLT2 antisense inhibitor, in multiple diabetic and euglycemic species","volume":"57","author":"Wancewicz","year":"2008","journal-title":"Diabetes"},{"key":"10.4158\/EP.14.6.782_bb0145","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1152\/ajplegacy.1962.202.1.149","article-title":"Effect of phlorizin on hepatic glucose output","volume":"202","author":"Kolodny","year":"1962","journal-title":"Am J Physiol"},{"key":"10.4158\/EP.14.6.782_bb0150","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.2337\/diabetes.48.9.1794","article-title":"T-1095, an inhibitor of renal Na+-glucose cotransporters, may provide a novel approach to treating diabetes","volume":"48","author":"Oku","year":"1999","journal-title":"Diabetes"},{"key":"10.4158\/EP.14.6.782_bb0155","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1016\/j.lfs.2004.09.038","article-title":"Long-term treatment with the Na+-glucose cotransporter inhibitor T-1095 causes sustained improvement in hyperglycemia and prevents diabetic neuropathy in Goto-Kakizaki rats","volume":"76","author":"Ueta","year":"2005","journal-title":"Life Sci"},{"key":"10.4158\/EP.14.6.782_bb0160","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1172\/JCI2720","article-title":"Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus","volume":"102","author":"Mevorach","year":"1998","journal-title":"J Clin Invest"},{"key":"10.4158\/EP.14.6.782_bb0165","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2337\/diabetes.49.5.701","article-title":"Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans","volume":"49","author":"Roden","year":"2000","journal-title":"Diabetes"},{"key":"10.4158\/EP.14.6.782_bb0170","first-page":"177","article-title":"Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying genes","volume":"5","author":"DeFronzo","year":"1997","journal-title":"Diabetes Rev"},{"key":"10.4158\/EP.14.6.782_bb0175","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.mcna.2004.04.013","article-title":"Pathogenesis of type 2 diabetes mellitus","volume":"8","author":"DeFronzo","year":"2004","journal-title":"Med Clin North Am"},{"key":"10.4158\/EP.14.6.782_bb0180","doi-asserted-by":"crossref","first-page":"610","DOI":"10.2337\/diacare.13.6.610","article-title":"Glucose toxicity","volume":"13","author":"Rossetti","year":"1990","journal-title":"Diabetes Care"},{"key":"10.4158\/EP.14.6.782_bb0185","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1254\/jjp.84.351","article-title":"Correction of hyperglycemia and insulin sensitivity by T-1095, an inhibitor of renal Na+-glucose cotransporters, in streptozotocininduced diabetic rats","volume":"84","author":"Oku","year":"2000","journal-title":"Jpn J Pharmacol"},{"key":"10.4158\/EP.14.6.782_bb0190","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.2174\/0929867043364360","article-title":"Glucose transporter and Na+\/glucose cotransporter as molecular targets of anti-diabetic drugs","volume":"11","author":"Asano","year":"2004","journal-title":"Curr Med Chem"},{"key":"10.4158\/EP.14.6.782_bb0195","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2337\/diab.37.6.667","article-title":"Lilly lecture 1987: the triumvirate; beta cell, muscle, liver; a collusion responsible for NIDDM","volume":"37","author":"DeFronzo","year":"1988","journal-title":"Diabetes"},{"key":"10.4158\/EP.14.6.782_bb0200","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.2337\/db05-1200","article-title":"Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study","volume":"55","author":"Abdul-Ghani","year":"2006","journal-title":"Diabetes"},{"key":"10.4158\/EP.14.6.782_bb0205","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2337\/diab.34.3.222","article-title":"The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus","volume":"34","author":"Garvey","year":"1985","journal-title":"Diabetes"},{"key":"10.4158\/EP.14.6.782_bb0210","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1172\/JCI113470","article-title":"Minimal chronic hyperglycemia is a critical determinant of impaired insulin secretion after an incomplete pancreatectomy","volume":"81","author":"Leahy","year":"1988","journal-title":"J Clin Invest"},{"key":"10.4158\/EP.14.6.782_bb0215","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1046\/j.1440-1681.2002.03671.x","article-title":"Beneficial effect of T-1095, a selective inhibitor of renal Na+-glucose cotransporters, on metabolic index and insulin secretion in spontaneously diabetic GK rats","volume":"29","author":"Nunoi","year":"2002","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"suppl 1","key":"10.4158\/EP.14.6.782_bb0220","first-page":"A188","article-title":"Dapagliflozin (BMS-512148), a selective inhibitor of the sodium-glucose uptake transporter 2 (SGLT2), reduces fasting serum glucose and glucose excursion in type 2 diabetes mellitus patients over 14 days","volume":"56","author":"Komoroski","year":"2007","journal-title":"Diabetes"},{"issue":"suppl 1","key":"10.4158\/EP.14.6.782_bb0225","first-page":"A461","article-title":"Dapagliflozin-induced glucosuria is accompanied by weight loss in type 2 diabetes patients","volume":"57","author":"List","year":"2008","journal-title":"Diabetes"},{"issue":"suppl 1","key":"10.4158\/EP.14.6.782_bb0230","first-page":"A329","article-title":"Efficacy and safety of dapagliflozin in a dose-ranging monotherapy study of treatment-na\u00efve patients with type 2 diabetes","volume":"57","author":"List","year":"2008","journal-title":"Diabetes"},{"issue":"suppl 1","key":"10.4158\/EP.14.6.782_bb0235","first-page":"A189","article-title":"Early clinical studies to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of single doses of sergliflozin, a novel inhibitor of renal glucose reabsorption, in healthy volunteers and subjects with type 2 diabetes mellitus","volume":"56","author":"Hussey","year":"2007","journal-title":"Diabetes"},{"issue":"suppl 1","key":"10.4158\/EP.14.6.782_bb0240","first-page":"A491","article-title":"A double-blind randomized repeat dose study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of three times daily dosing of sergliflozin, a novel inhibitor of renal glucose reabsorption, in healthy overweight and obese subjects","volume":"56","author":"Hussey","year":"2007","journal-title":"Diabetes"},{"key":"10.4158\/EP.14.6.782_bb0245","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1172\/JCI114700","article-title":"Progressive increases in luminal glucose stimulate proximal sodium absorption in normal and diabetic rats","volume":"86","author":"Bank N","year":"1990","journal-title":"J Clin Invest"},{"key":"10.4158\/EP.14.6.782_bb0250","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1056\/NEJM199611283352203","article-title":"(Diabetic Renal Disease Study Group). Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus","volume":"335","author":"Nelson","year":"1996","journal-title":"N Engl J Med"},{"key":"10.4158\/EP.14.6.782_bb0255","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1056\/NEJM199106063242304","article-title":"Effect of strict glycemic control on renal hemodynamic response to amino acids and renal enlargement in insulin-dependent diabetes mellitus [published correction appears in N Engl J Med. 1991;325:1686]","volume":"324","author":"Tuttle","year":"1991","journal-title":"N Engl J Med"},{"key":"10.4158\/EP.14.6.782_bb0260","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","article-title":"The pathobiology of diabetic complications: a unifying mechanism","volume":"54","author":"Brownlee","year":"2005","journal-title":"Diabetes"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20412960?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20412960?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/38033757N0415736.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:48:32Z","timestamp":1761515312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20412960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S1530891X20412960"],"URL":"https:\/\/doi.org\/10.4158\/ep.14.6.782","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of Renal Glucose Reabsorption: A Novel Strategy for Achieving Glucose Control in Type 2 Diabetes Mellitus","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP.14.6.782","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}